BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32777192)

  • 1.
    Dube Y; Khan A; Marimani M; Ahmad A
    Can J Microbiol; 2020 Dec; 66(12):733-747. PubMed ID: 32777192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.
    Matsubara VH; Wang Y; Bandara HMHN; Mayer MPA; Samaranayake LP
    Appl Microbiol Biotechnol; 2016 Jul; 100(14):6415-6426. PubMed ID: 27087525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of Lactobacillus rhamnosus and Lactobacillus casei on Candida biofilm of denture surface.
    Song YG; Lee SH
    Arch Oral Biol; 2017 Apr; 76():1-6. PubMed ID: 28063305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans.
    Köhler GA; Assefa S; Reid G
    Infect Dis Obstet Gynecol; 2012; 2012():636474. PubMed ID: 22811591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis.
    Rossoni RD; de Barros PP; de Alvarenga JA; Ribeiro FC; Velloso MDS; Fuchs BB; Mylonakis E; Jorge AOC; Junqueira JC
    Biofouling; 2018 Feb; 34(2):212-225. PubMed ID: 29380647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicans.
    Oliveira VM; Santos SS; Silva CR; Jorge AO; Leão MV
    J Appl Microbiol; 2016 Dec; 121(6):1737-1744. PubMed ID: 27606962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 exhibit strong antifungal effects against vulvovaginal candidiasis-causing Candida glabrata isolates.
    Chew SY; Cheah YK; Seow HF; Sandai D; Than LT
    J Appl Microbiol; 2015 May; 118(5):1180-90. PubMed ID: 25688886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactobacillus species increase the survival of Galleria mellonella infected with Candida albicans and non-albicans Candida clinical isolates.
    Santos RB; Scorzoni L; Namba AM; Rossoni RD; Jorge AOC; Junqueira JC
    Med Mycol; 2019 Apr; 57(3):391-394. PubMed ID: 29796666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus rhamnosus inhibits Candida albicans virulence factors in vitro and modulates immune system in Galleria mellonella.
    Ribeiro FC; de Barros PP; Rossoni RD; Junqueira JC; Jorge AO
    J Appl Microbiol; 2017 Jan; 122(1):201-211. PubMed ID: 27727499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal defense of probiotic Lactobacillus rhamnosus GG is mediated by blocking adhesion and nutrient depletion.
    Mailänder-Sánchez D; Braunsdorf C; Grumaz C; Müller C; Lorenz S; Stevens P; Wagener J; Hebecker B; Hube B; Bracher F; Sohn K; Schaller M
    PLoS One; 2017; 12(10):e0184438. PubMed ID: 29023454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Candida albicans morphogenesis by chitinase from Lactobacillus rhamnosus GG.
    Allonsius CN; Vandenheuvel D; Oerlemans EFM; Petrova MI; Donders GGG; Cos P; Delputte P; Lebeer S
    Sci Rep; 2019 Feb; 9(1):2900. PubMed ID: 30814593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium deprivation affects cellular circuitry involved in drug resistance and virulence in Candida albicans.
    Hans S; Fatima Z; Hameed S
    J Glob Antimicrob Resist; 2019 Jun; 17():263-275. PubMed ID: 30659981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
    Cui J; Ren B; Tong Y; Dai H; Zhang L
    Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Yeasts Inhibit Virulence of Non
    Kunyeit L; Kurrey NK; Anu-Appaiah KA; Rao RP
    mBio; 2019 Oct; 10(5):. PubMed ID: 31615960
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Romo JA; Pierce CG; Esqueda M; Hung CY; Saville SP; Lopez-Ribot JL
    Front Cell Infect Microbiol; 2018; 8():227. PubMed ID: 30042929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lactobacillus rhamnosus may change the virulence of Candida albicans].
    Leão MV; Gonçalves e Silva CR; Santos SS; Leite PG
    Rev Bras Ginecol Obstet; 2015 Sep; 37(9):417-20. PubMed ID: 26313880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.
    Rossoni RD; Dos Santos Velloso M; Figueiredo LMA; Martins CP; Jorge AOC; Junqueira JC
    Folia Microbiol (Praha); 2018 May; 63(3):307-314. PubMed ID: 29170992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H; Ahmad I
    J Mycol Med; 2020 Apr; 30(1):100911. PubMed ID: 32008964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lactobacillus rhamnosus Lcr35 as an effective treatment for preventing Candida albicans infection in the invertebrate model Caenorhabditis elegans: First mechanistic insights.
    Poupet C; Saraoui T; Veisseire P; Bonnet M; Dausset C; Gachinat M; Camarès O; Chassard C; Nivoliez A; Bornes S
    PLoS One; 2019; 14(11):e0216184. PubMed ID: 31693670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Candida albicans biofilm and hyphae formation by biocompatible oligomers.
    Lee JH; Kim YG; Lee J
    Lett Appl Microbiol; 2018 Aug; 67(2):123-129. PubMed ID: 29885256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.